David Miles Meredith, M.D.,Ph.D.
This page shows the publications David Meredith has written about Proto-Oncogene Proteins.
Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. J Neuropathol Exp Neurol. 2019 04 01; 78(4):305-314.
Mapping the minimal domain of hMSH-2 sufficient for binding mismatched oligonucleotides. Biochem Biophys Res Commun. 1997 Mar 06; 232(1):10-3.
Mutational analysis of the nucleotide binding domain of the mismatch repair enzyme hMSH-2. Biochem Biophys Res Commun. 1996 Dec 04; 229(1):147-53.
A carboxy terminal domain of the hMSH-2 gene product is sufficient for binding specific mismatched oligonucleotides. Biochem Biophys Res Commun. 1996 Aug 05; 225(1):289-95.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.